How do you approach initial serologic evaluation for patients referred with reactive lymphadenopathy, but no clear signs or symptoms of active rheumatologic disease?
How do you approach initial serologic evaluation for patients referred with reactive lymphadenopathy, but no clear signs or symptoms of active rheumatologic disease? | Mednet
